Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001657312-24-000031
Filing Date
2024-11-04
Accepted
2024-11-04 08:47:12
Documents
52
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q vrna-20240930.htm   iXBRL 10-Q 1243579
2 EX-31.1 exhibit311q324.htm EX-31.1 8960
3 EX-31.2 exhibit312q324.htm EX-31.2 9002
4 EX-32.1 exhibit321q324.htm EX-32.1 5243
5 EX-32.2 exhibit322q324.htm EX-32.2 5326
11 GRAPHIC vrna-20240930_g1.jpg GRAPHIC 157409
  Complete submission text file 0001657312-24-000031.txt   4899015

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20240930.xsd EX-101.SCH 29805
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20240930_cal.xml EX-101.CAL 50202
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20240930_def.xml EX-101.DEF 94044
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20240930_lab.xml EX-101.LAB 413121
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20240930_pre.xml EX-101.PRE 262484
55 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20240930_htm.xml XML 406193
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38067 | Film No.: 241420971
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)